BBA
NBIX icon

Baker Bros. Advisors’s Neurocrine Biosciences NBIX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-676,975
Closed -$63.5M 120
2022
Q1
$63.5M Hold
676,975
0.36% 24
2021
Q4
$57.7M Hold
676,975
0.28% 33
2021
Q3
$64.9M Hold
676,975
0.29% 31
2021
Q2
$65.9M Hold
676,975
0.29% 31
2021
Q1
$65.8M Hold
676,975
0.29% 32
2020
Q4
$64.9M Hold
676,975
0.24% 27
2020
Q3
$65.1M Sell
676,975
-230,011
-25% -$22.1M 0.26% 24
2020
Q2
$111M Sell
906,986
-333,257
-27% -$40.7M 0.49% 17
2020
Q1
$107M Sell
1,240,243
-14,000
-1% -$1.21M 0.66% 15
2019
Q4
$135M Sell
1,254,243
-161,040
-11% -$17.3M 0.72% 16
2019
Q3
$128M Hold
1,415,283
0.87% 12
2019
Q2
$119M Buy
1,415,283
+316,613
+29% +$26.7M 0.81% 14
2019
Q1
$96.8M Buy
1,098,670
+368,315
+50% +$32.4M 0.62% 16
2018
Q4
$52.2M Sell
730,355
-214,269
-23% -$15.3M 0.43% 22
2018
Q3
$116M Hold
944,624
0.77% 15
2018
Q2
$92.8M Hold
944,624
0.7% 16
2018
Q1
$78.3M Sell
944,624
-60,000
-6% -$4.98M 0.66% 17
2017
Q4
$77.9M Buy
1,004,624
+387,942
+63% +$30.1M 0.68% 15
2017
Q3
$37.8M Hold
616,682
0.31% 23
2017
Q2
$28.4M Sell
616,682
-278,740
-31% -$12.8M 0.25% 26
2017
Q1
$38.8M Hold
895,422
0.32% 23
2016
Q4
$34.7M Hold
895,422
0.34% 24
2016
Q3
$45.3M Hold
895,422
0.41% 25
2016
Q2
$40.7M Hold
895,422
0.43% 24
2016
Q1
$35.4M Buy
895,422
+44,683
+5% +$1.77M 0.37% 29
2015
Q4
$48.1M Buy
850,739
+100,000
+13% +$5.66M 0.4% 28
2015
Q3
$29.9M Buy
750,739
+208,503
+38% +$8.3M 0.28% 27
2015
Q2
$25.9M Hold
542,236
0.23% 40
2015
Q1
$21.5M Sell
542,236
-12,354
-2% -$491K 0.18% 42
2014
Q4
$12.4M Hold
554,590
0.13% 45
2014
Q3
$8.69M Hold
554,590
0.11% 46
2014
Q2
$8.23M Buy
554,590
+106,716
+24% +$1.58M 0.1% 48
2014
Q1
$7.21M Buy
+447,874
New +$7.21M 0.09% 58